TICKERNERD
Menu
AVRAVRHealthcare · Medical Devices

AVR Stock Forecast: Anteris Technologies Global Corp. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$8.37
+0.78% on the day

The 3 Wall Street analysts covering Anteris Technologies Global Corp. hold a median 12-month price target of $15 — +79.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 22 of 100 as at 12 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$815.2M
Ticker Nerd rank
22 / 100
Median analyst target
$15
Analysts covering
3
Revenue$1.0M+63.3% y/y
Operating income−$31.0M
Net income−$28.8M
Free cash flow−$21.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−4.1%
1M
−8.8%
YTD
+67.6%
1Y
+67.3%
From 52W high
−20.9%
From 52W low
+147.5%
$3
$11
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AVR stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Anteris Technologies Global Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
22 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
90
Growth
71
Size
47
Accruals
42
Revisions
31
Issuance
19
Value
19
Volatility
14
Quality
10

Momentum (90): The shares have been drifting up relative to others.

Quality (10): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AVR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AVR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15Oct 25Jan 26Apr 26Jul 26AVRHigh $16Median $15Low $15

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $15Median $15High $16

The green dot is the last close — the median target sits +79.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 Aug 2026Cantor FitzgeraldReiteratesOverweight$15
15 May 2026BarclaysMaintainsOverweight$17 → $18
15 May 2026BarclaysMaintainsOverweight—
27 Mar 2026Cantor FitzgeraldReiteratesOverweight—
12 Mar 2026Cantor FitzgeraldAssumesOverweight$15
11 Mar 2026Wells FargoInitiatesOverweight—
8 Jan 2025Lake StreetInitiatesBuy—
7 Jan 2025BarclaysInitiatesOverweight—
7 Jan 2025Cantor FitzgeraldInitiatesOverweight—
7 Jan 2025TD CowenInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AVR appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

AVR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Anteris Technologies Global Corp. returned +67.3% against +17.5% for the S&P 500, dividends included.

AVR vs S&P 500, last 12 monthsTotal return, rebased to 100
50100150200Oct 25Jan 26Apr 26Jul 26AVRS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AVR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
2
Fundamentals

Anteris Technologies Global Corp. (AVR) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−3.3×

Cheaper than 88% of US stocks

Price / sales
363.0×

Cheaper than 2% of US stocks

Price / book
3.2×

Cheaper than 31% of US stocks

EV / EBITDA
−5.4×

Cheaper than 79% of US stocks

Growth & margins
Revenue growth (YoY)
63.3%

Higher than 89% of US stocks

Earnings growth (YoY)
63.3%

Higher than 78% of US stocks

Gross margin
76.9%

Higher than 89% of US stocks

Operating margin
−3072.1%

Higher than 4% of US stocks

Net margin
70.3%

Higher than 98% of US stocks

Returns & dividend
Return on equity
−74.7%

Higher than 17% of US stocks

Return on assets
−42.5%

Higher than 10% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Anteris Technologies Global Corp. (AVR) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Anteris Technologies Global Corp. has a market value of $815.2M and an enterprise value of $560.5M.

  • Revenue in the twelve months to 30 June 2026: $2.2M. The latest quarter grew 63.3% year on year.

  • Net income over the same four quarters: −$102.9M, a −4590.0% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$88.3M.

  • Shares outstanding: 97.4M.

  • Trailing P/E: −3.3×; forward P/E: −8.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Anteris Technologies Global Corp. employs 174 people — $13K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

AVR vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
AVRAnteris Technologies Global Corp.$815.2M
22
SIBNSI-BONE, Inc.$811.8M
74
QDELQuidelOrtho Corp.$803.3M
35
AHCOAdaptHealth Corp.$823.6M
43
VREXVarex Imaging Corp.$773.8M
80
INMDInMode Ltd.$856.5M
76
CBLLCeribell, Inc.$876.6M
36

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Anteris Technologies Global Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AVR news & analysis

Anteris to Present at September Healthcare Investor Conferences

GlobeNewsWire · 31 Aug 2026neutral

Anteris Technologies Global Corp. announced that Vice Chairman and CEO Wayne Paterson will present at three September 2026 healthcare investor conferences: the Cantor Global Healthcare Conference, the Wells Fargo 21st Annual Healthcare Conference, and the Morgan Stanley 24th Annual Global Healthcare Conference, featuring fireside chats and one-on-one meetings.

Why it matters — AVR watchers would monitor these presentations as an opportunity for the company's leadership to engage with investors and analysts at major healthcare conferences.

Anteris Technologies Announces Results for the Second Quarter of 2026

GlobeNewsWire · 11 Aug 2026positive

Anteris Technologies Global Corp. reported its financial results for the quarter ended June 30, 2026, and provided a corporate update. The company announced that it secured U.S. Medicare reimbursement eligibility for its global pivotal PARADIGM Trial under a CMS national coverage policy, enabling reimbursement for eligible procedures at U.S. sites.

Why it matters — The Medicare reimbursement eligibility for the PARADIGM Trial is a significant regulatory milestone that could support the company's U.S. clinical and commercial pathway for its medical device.

FAQ

Frequently asked questions about AVR stock

What is the AVR stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Anteris Technologies Global Corp. have a median 12-month price target of $15, with estimates ranging from $15 to $16. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AVR stock a buy right now?

Of the 3 analysts covering Anteris Technologies Global Corp., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Anteris Technologies Global Corp. 22 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AVR?

As at 12 Sept 2026, Anteris Technologies Global Corp. ranks 22 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (90 of 100).

Will AVR stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +79.3% from the last close, and Ticker Nerd's factor model ranks Anteris Technologies Global Corp. 22 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AVR stock forecast for 2030?

No analyst covering Anteris Technologies Global Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $15 to $16 over the next 12 months.

How has AVR stock performed over the past year?

Anteris Technologies Global Corp. returned +67.3% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Anteris Technologies Global Corp. do?

Anteris Technologies Global Corp. is a structural heart company focused on designing, developing, and commercializing minimally invasive medical devices for heart valve disease.

What is the latest news on AVR?

The most recent item we track (GlobeNewsWire, 31 Aug 2026): "Anteris to Present at September Healthcare Investor Conferences". Anteris Technologies Global Corp. announced that Vice Chairman and CEO Wayne Paterson will present at three September 2026 healthcare investor conferences: the Cantor Global Healthcare Conference, the Wells Fargo 21st Annual Healthcare Conference, and the Morgan Stanley 24th Annual Global Healthcare Conference, featuring fireside chats and one-on-one meetings.

Company

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a structural heart company focused on designing, developing, and commercializing minimally invasive medical devices for heart valve disease. Its portfolio centers on transcatheter aortic valve replacement systems and related technologies intended to restore healthy heart function in patients with aortic stenosis. The company also works on complementary structural heart solutions, including specialized tissue materials and delivery systems that support precise implantation and procedural performance. Anteris Technologies Global Corp. serves the cardiovascular care market, where its products are used by physicians and cardiac specialists in treatment settings that require advanced device-based interventions. With operations spanning multiple regions, the company plays a role in the broader medical technology sector by addressing the needs of patients and clinicians seeking catheter-based alternatives for heart valve repair and replacement.

CEO Mr. Wayne Geoffrey Paterson · 174 employees · Australia · https://anteristech.com